Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Tango Therapeutics Inc (TNGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	09-2010	06-2010	03-2010	12-2009	09-2009
Cash Flows From Operating Activities
Net Income	-1,213	-1,110	-875	-2,554	N/A
Depreciation Amortization	2,694	1,807	902	3,729	N/A
Income taxes - deferred	143	95	48	190	N/A
Accounts receivable	-2,396	-2,850	-1,379	-141	N/A
Accounts payable and accrued liabilities	569	337	347	113	N/A
Other Working Capital	-1,242	-1,716	-1,403	116	N/A
Other Operating Activity	3,588	3,797	1,902	978	0
Operating Cash Flow	$2,143	$360	$-458	$2,431	$N/A

Cash Flows From Investing Activities
PPE Investments	-319	-236	-157	-660	N/A
Net Acquisitions	N/A	N/A	N/A	-70	N/A
Investing Cash Flow	$-319	$-236	$-157	$-730	$N/A

Cash Flows From Financing Activities
Debt Repayment	-3,646	-2,231	-1,463	-1,476	N/A
Common Stock Issued	51	36	28	77	N/A
Other Financing Activity	0	0	0	-693	0
Financing Cash Flow	$-3,595	$-2,195	$-1,435	$-2,092	$N/A

Beginning Cash Position	6,163	6,163	6,163	6,554	N/A
End Cash Position	4,392	4,092	4,114	6,163	N/A
Net Cash Flow	$-1,771	$-2,071	$-2,050	$-391	$N/A

Free Cash Flow
Operating Cash Flow	2,143	360	-458	2,431	N/A
Capital Expenditure	-319	-236	-157	-660	N/A
Free Cash Flow	1,824	124	-615	1,771	0